Hematology Overview: Anemias, Hematopoiesis, and Blood Disorders

Polycythemia Overview

Definition: Polycythemia refers to the overproduction of red blood cells (RBCs).
Causes:
- Resulting from dehydration, which leads to an increase in red blood cell mass, hemoglobin (Hgb), and hematocrit (He I) values.

Definition: A myeloproliferative neoplasm characterized by a mutation in the JAK2 gene, causing the erythropoietin receptor to remain active.
Clinical Implications:
- Can convert to acute myeloid leukemia (AML).
Symptoms:
- Splenomegaly (enlarged spleen)
- Thrombosis, bleeding problems (TBP)
- Aquagenic pruritus (itching when in contact with water)
Treatment:
- Phlebotomy (removal of blood)
- Low dose aspirin
- Interferon-alpha
- Hydroxyurea
- Radioactive phosphorus

Function: Site for hematopoiesis (blood cell formation) in adults, involving both endosteal and vascular niches which control the differentiation and self-renewal of hematopoietic stem cells.
Areas of differentiation:
- Spleen pulp (lymphoid tissue)
- Venous sinus (red marrow)
- Total volume: 300 mL

Spleen:
- Historically important for hematopoiesis in the fetus.
- Responsible for producing plasma cells.
Liver:
- Also a key organ for fetal hematopoiesis.
- Function: Filters blood and manages hemoglobin carrying capacity (each hemoglobin molecule can carry 4 O₂ molecules).
- Contains Kupffer cells which help remove old RBCs.
- Iron storage is managed through ferritin and apoferritin (ferritin without iron).
Kidney’s Role:
- Produces erythropoietin, particularly in response to hypoxic conditions.

Divided into:
- Endosteal (supporting cells)
- Vascular (mesenchymal stem cells)
- Associated Chemokines: CXCL12 (also referred to as SDF-1).
Yellow marrow (no blood cells) can transform into red marrow (blood cell producing).
Erythropoietin hormone initiates erythrocyte production.

Initiation occurs during the embryonic phase, starting in the yolk sac.
By 2 weeks of gestation, erythrocytes are functional and delivering O₂ to tissues.
Pre-birth, there exists a hypoxic environment, stimulating increased EPO levels.
- After birth, the environment becomes normoxic, altering EPO cell production dynamics.
Timeline of Erythrocyte Production:
- 8 weeks gestation: Production begins in the yolk sac.
- Peaks at liver sinusoids around 4 months, shifting to marrow by 5 months gestation.
Clinical Measurements:
- 2,3 DPG causes right shift (decreased affinity) in hemoglobin's oxygen-carrying capacity.

Thrombin inhibitors:
- Antithrombin, Protein C, and S degrade clotting factors.
Common Anticoagulants:
- Rivaroxaban, Apixaban (inhibits Factor Xa, converting prothrombin into thrombin).
Role of Vitamin K in coagulation:
- Essential for the synthesis of Factors II, VII, IX, and X, as well as Protein C and S.
- Warfarin acts as a Vitamin K antagonist.
Platelet function:
- P2Y1 receptor interactions modulated by ADP; as platelets aggregate via activation from substances like Clopidogrel and Prasugrel.
Urokinase and Streptokinase functions are related to clot resolution.

Condition resulting from Vitamin B12 deficiency, leading to neuropsychiatric symptoms and macrocytic RBCs (7-8 micrometers).
Clinical manifestations: tingling sensations, ataxia, beefy red tongue, jaundice, splenomegaly, neurological symptoms due to demyelination.

Folate is essential for RNA and DNA synthesis, with common causes being malnutrition and alcohol consumption.
Associated with neural tube defects during fetal development, symptoms include dysphagia, diarrhea, and oral lesions.
Treatment includes oral folate supplementation.

Definition: Characterized by increased destruction of RBCs.
Types include:
- Paroxysmal nocturnal hemoglobinuria (deficiency in CD55 and CD59, causing hemolysis and hemoglobinuria).
- Autoimmune hemolytic anemia (autoantibodies target erythrocyte antigens).
- Drug-induced hemolytic anemia due to reactions to medications (e.g., penicillin).
Clinical manifestations include anemia, fatigue, pain, and potential thrombosis.
Treatment involves corticosteroids, splenectomy, and supportive care.

Cause: Decreased erythropoiesis due to infections, cancers, inflammation, or autoimmune diseases, leading to increased levels of lactoferrin and apoferrin.
Symptoms may depict kidney damage due to inflammation-induced iron binding.

Definition: Pancytopenia due to loss of all three types of blood cells, often resulting from drugs, chemicals, or genetic conditions like Fanconi Anemia (defects in DNA repair).
Clinical manifestations: hypoxemia, pallor, brown skin changes.
Treatment involves bone marrow transplantation and immunosuppressive therapy.

Most common hemolytic disorder not involving hemoglobin abnormalities, related to deficiencies in spectrin and ankyrin.
Clinical manifestations: Anemia, jaundice, and splenomegaly.
Diagnosis is usually through history, blood smear, and osmotic fragility tests.
Management may include folate supplementation and partial splenectomy.

Definition: Autosomal recessive disorder affecting hemoglobin synthesis.
Types:
- Major (homozygous)
- Minor (heterozygous)
Common regions: Africa, Asia, and the Mediterranean.
- Beta major (Cooley's Anemia)
- Alpha minor: HbH disease is serious.
Evaluation includes the presence of D-antigen and Rh status.

Genetic disorder (autosomal recessive) leading to the production of hemoglobin S (HbS) which can solidify or stretch during dehydration, leading to sickle cell formations.
Sickle-celled trait indicates carriers (heterozygous) typically exhibit no symptoms.
Manifestation depends on the percentage of hemoglobin S present.
- Crisis states include pain, acute chest syndrome, aplastic crisis (due to viral infections), sequestration crisis, and hyperhemolytic crisis.
Management strategies:
- Preventing crisis through hydration, managing acidosis, routine vaccinations, and providing antibiotics.
Pain management is critical, given the high mortality associated with crisis states.